Medical Innovation Exchange

Merck & Co. bails on NGM eye disease collab in wake of phase 2 fail

https://www.fiercebiotech.com/biotech/merck-co-bails-ngm-eye-disease-collab-wake-phase-2-fail

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!